Director, Medical Affairs Oncology

Corcept is engaged in the discovery and development of drugs that treat severe endocrine, metabolic, oncologic and neurological disorders by modulating the effects of the hormone cortisol. Since 2012, we have marketed Korlym ® for the treatment of patients suffering from Cushing's syndrome, a life-threatening orphan disorder caused by excess cortisol activity.

In addition to our commercial product, Korlym, we have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators. Lead compounds are in Phase 2 and Phase 3 trials for the treatment of patients with Cushing's syndrome, advanced ovarian cancer, castration-resistant prostate cancer, weight gain caused by antipsychotic medications and non-alcoholic steatohepatitis ("NASH"). We are about to start a Phase 2 trial in patients with amyotrophic lateral sclerosis ("ALS").

In 2021, we generated revenue of $366 million and net income of $112 million.

The Director, Medical Affairs Oncology will serve as a scientific peer within the Gynecological Oncology medical community and the overall oncology medical community. He/she is responsible for developing and enhancing professional relationships with key opinion leaders (KOLs), professional organizations, and patient organizations. This individual will be responsible for building the MSL team in the United States in support of the relacorilant launch in platinum resistant ovarian cancer.

Responsibilities:

• Demonstrate medical leadership and expertise by engaging in peer to peer interactions within the gynecological oncology community. Develop the KOL engagement plan. Establish and build relationships with key opinion leaders (KOLs), professional organizations, and patient organizations.
• Raise awareness for the role of cortisol modulation in oncology. Communicate scientific evidence related to Corcept oncology programs and advance the Corcept oncology scientific platform.
• Develop scientific resources for external education. Deliver clinical presentations and communicate scientific data in one on one interactions, at key medical and scientific congresses, and other forums.
• Build and lead the Medical Science Liaison team in the United States in support of the relacorilant launch in platinum resistant ovarian cancer.
• Contribute to developing Medical Affairs strategies in support of the relacorilant launch and oncology development programs.
• Interact with investigators to support enrollment of oncology clinical trials.
• Develop the plan for presence, coverage and KOL engagement at key congresses and meetings.
• Communicate insights and issues from field interactions to internal stakeholders.
• Maintain a deep knowledge in gynecological oncology and a broad understanding of other relevant oncology indications.
• Participate in the identification and publication of scientific materials.
• Facilitate scientific exchange within legal, compliance and regulatory guidelines.

Preferred Skills, Qualifications and Technical Proficiencies:

• Scientific degree required (PharmD, MD, or PhD) with 10+ years relevant experience (clinical practice, academic, and or industry) and at least 5 years MSL field experience in the pharmaceutical or biotech industry is preferred.
• Thorough grasp of treatment guidelines, clinical research processes, FDA regulations, and ethical guidelines as applied to the pharmaceutical industry.
• Strong track record of maintaining positive relationships with key stakeholders.
• Demonstrated leadership and ability to perform effectively in a dynamic environment.
• Strong interpersonal, organizational, team, written and verbal communication skills.
• Sound judgement in handling complex, confidential and regulated information.
• Experience in Oncology is required.
• Experience working as a supervisor of people is required.
• Launch experience preferred.
• Ability to travel up to 50-70%.

The pay range that the Company reasonably expects to pay for this position is $234,100 - $275,400; the pay ultimately offered may vary based on legitimate considerations, including job-related knowledge, skills, experience, and education. An annual cash bonus and equity grants may be provided as part of the overall compensation package, in addition to a full range of medical, financial, and/or other wellness benefits, dependent on the position offered.

Applicants must be currently authorized to work in the United States on a full-time basis.

If you are based in California, we encourage you to read this important information for California residents linked here.

Corcept appreciates the commitment and hard work of all our team members as we strive to discover and develop novel treatments for patients with serious unmet medical needs.

Please visit our website at: https://www.corcept.com/

Corcept is an Equal Opportunity Employer